Series C Investors & VC Firms in Global
943 firms in this list, with a median first check of $1M. 233 of them lead rounds. Generated from verified public data and updated continuously.
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
12 people
Antler Australia
SydneyPre-Seed–Growth$3M – $10M
13 people
UMC Capital
TaipeiSeed–Late Stage
20 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
16 people
Pangaea Ventures Us Inc.
VancouverSeed–Late Stage$500K – $1.5M
13 people
Eurazeo
ParisSeries A–Late Stage
12 people
Tal Ventures
Tel AvivPre-Seed–Late Stage$3M – $120M
7 people
Avaana Capital
MumbaiSeed–Late Stage
18 people
HG Ventures
IndianapolisPre-Seed–Growth$1M – $10M
12 people
Dentsu Ventures
TokyoSeed–Late Stage
11 people
Scottish Equity Partners
LondonSeries A–Late Stage$2.5M – $31.8M
20 people
Fulgur Ventures
WilmingtonPre-Seed–Late Stage
4 people
Btomorrow Ventures
LondonSeed–Growth
18 people
MESH
TaipeiSeed–Late Stage$100K – $60M
17 people
Industry Ventures
San FranciscoPre-Seed–Late Stage$250K – $50M
10 people
Alpha Intelligence Capital
San FranciscoSeed–Series C
15 people
Akkadian Ventures
San FranciscoSeed–Late Stage$250K – $10M
11 people
Alacrity Canada
VictoriaPre-Seed–Late Stage
29 people
BAI capital
BeijingSeed–Growth$3M – $100M
23 people
Delos Capital
CambridgeSeed–Late Stage
17 people
Inven Capital
PragueSeed–Late Stage$2.2M – $33M
17 people
Jerusalem Venture Partners (JVP)
JerusalemSeed–Late Stage$1.5M – $43M
19 people
Blue Horizon Corporation
ZurichPre-Seed–Late Stage
Ajax Health
Menlo ParkSeed–Late Stage
26 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Seed Investors & VC Firms (10975)Series A Investors & VC Firms (8160)Pre-Seed Investors & VC Firms (5955)Seed Investors & VC Firms in North America (5705)Investors & VC Firms in Europe (5528)Seed Investors & VC Firms in United States (5128)Growth Investors & VC Firms (4870)Series A Investors & VC Firms in North America (4605)
Data sourced from public filings and firms' own websites — see our methodology.




































































































